Table 3.
Indications of antimicrobial therapy.
| Indication | Number | Imipenem-cilastatin n = 776 |
Meropenem n = 1021 |
Piperacillin-tazobactam n = 3208 |
|---|---|---|---|---|
| Febrile neutropenia | 199 | 21 (2.7%) | 27 (2.6%) | 151 (4.7%) |
| Gynaecological infection | 5 | 0 (0%) | 0 (0%) | 5 (0.2%) |
| Intra-abdominal infection | 431 | 54 (7%) | 53 (5.2%) | 324 (10.1%) |
| Meningitis | 8 | 0 (0%) | 3 (0.2%) | 5 (0.2%) |
| Osteomyelitis | 25 | 5 (0.6%) | 9 (0.9%) | 11 (0.3%) |
| Pneumonia | 1333 | 122 (15.7%) | 203 (19.9%) | 1008 (31.4%) |
| Sepsis | 1248 | 257 (33.1%) | 359 (35.2%) | 632 (19.7%) |
| Skin and soft tissue infection | 743 | 130 (16.8%) | 130 (12.7%) | 483 (15.1%) |
| Urinary tract infection | 864 | 181 (23.3%) | 213 (20.9%) | 470 (14.7%) |
| aOther | 7 | 0 (0%) | 3 (0.3%) | 4 (0.1%) |
| Prophylaxis | ||||
| Surgical prophylaxis | 102 | 3 (0.4%) | 8 (0.8%) | 91 (2.8%) |
| bOther prophylaxis | 40 | 3 (0.4%) | 13 (1.3%) | 24 (0.7%) |
a
Other includes endocarditis and acute otitis externa.
b
Other prophylaxis includes trauma, burn and bite.